Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AptarGroup, Inc. Common Stock (NY:ATR)

123.23 +0.48 (+0.39%)
Streaming Delayed Price Updated: 3:44 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about AptarGroup, Inc. Common Stock

< Previous 1 2 3 4 Next >
News headline image
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
From Aptar Group, Inc.
Via Business Wire
News headline image
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Reports Third Quarter 2025 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers
From Aptar Digital Health
Via Business Wire
News headline image
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Announces 2025 Investor Day
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Reports Second Quarter 2025 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Named One of the World’s Most Sustainable Companies by TIME for Second Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar to Participate in Upcoming Investor Conferences
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Releases 2024 Corporate Sustainability Report
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Reports First Quarter 2025 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Reports Fourth Quarter and Annual 2024 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Sixth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Announces 2025 Quarterly Conference Call Dates
From Aptar
Via Business Wire
News headline image
Aptar to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Named Among Top 50 of the ‘World’s Top Companies for Women 2024’ by Forbes
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Reports Third Quarter 2024 Results
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
From AptarGroup, Inc.
Via Business Wire
News headline image
Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
From AptarGroup, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.